TRANSLATE BIO, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 35220
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 19148
 
  
 
C07K PEPTIDES 10126
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 891
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4134
 
  
 
C07D HETEROCYCLIC COMPOUNDS 4158
 
  
 
C07J STEROIDS316
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0028,445 CNS DELIVERY OF MRNA AND USES THEREOFAug 14, 17Feb 01, 18[A61K, C12N]
2018/0008,543 Cleavable LipidsJul 17, 17Jan 11, 18[A61K, C12N, C07D, C07C, C07J]
2018/0008,680 Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase DeficiencyJun 13, 17Jan 11, 18[A61K]
2017/0348,244 ENCAPSULATION OF MESSENGER RNAApr 24, 17Dec 07, 17[A61K]
2017/0246,319 BIODEGRADABLE LIPIDS FOR DELIVERY OF NUCLEIC ACIDSMay 29, 15Aug 31, 17[A61K, C07D]
2017/0143,848 MRNA THERAPY FOR THE TREATMENT OF OCULAR DISEASESMar 19, 15May 25, 17[A61K]
2016/0184,458 MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERSMar 14, 14Jun 30, 16[A61K]
2016/0122,727 MESSENGER RNA BASED VIRAL PRODUCTIONJun 12, 14May 05, 16[A61K, C12N]
2016/0002,705 QUANTITATIVE ASSESSMENT FOR CAP EFFICIENCY OF MESSENGER RNAMar 14, 14Jan 07, 16[C12Q]
2015/0376,220 METHODS FOR PURIFICATION OF MESSENGER RNAApr 24, 15Dec 31, 15[C07H]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9877919 Lipid-derived neutral nanoparticlesMar 29, 13Jan 30, 18[A61K, C12N]
9850269 Methods for purification of messenger RNAApr 24, 15Dec 26, 17[C07H, C12Q, C12N]
9717690 Cleavable lipidsJun 08, 12Aug 01, 17[A61K, C07D, C12N, C07C, C07J]
9713626 CFTR mRNA compositions and related methods and usesOct 06, 15Jul 25, 17[A61K, C07H, C12N, C07K]
9668980 Encapsulation of messenger RNAJul 02, 15Jun 06, 17[A61K]
9629804 Lipid formulations for delivery of messenger RNAOct 22, 14Apr 25, 17[A61K]
9597413 Pulmonary delivery of mRNAJun 18, 14Mar 21, 17[A61K, C12N, C07K]
9546128 Ionizable cationic lipidsMar 29, 13Jan 17, 17[A61K, C12N, C07C]
9522176 MRNA therapy for phenylketonuriaOct 22, 14Dec 20, 16[A61K, C07H, C12N]
9308281 MRNA therapy for Fabry diseaseJun 18, 14Apr 12, 16[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0110,857 CNS DELIVERY OF MRNA AND USES THEREOFAbandonedOct 22, 14Apr 23, 15[A61K]
2014/0294,940 MRNA THERAPY FOR UREA CYCLE DISORDERSAbandonedJun 19, 14Oct 02, 14[A61K]
2014/0206,753 LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERYAbandonedJun 08, 12Jul 24, 14[C12N]
2011/0244,026 DELIVERY OF MRNA FOR THE AUGMENTATION OF PROTEINS AND ENZYMES IN HUMAN GENETIC DISEASESAbandonedNov 30, 10Oct 06, 11[A61K, A61P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.